Apraclonidine hydrochloride
CAS: 73218-79-8
Ref. TM-T21371
| 1mg | 36.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 207.00 € | ||
| 50mg | 305.00 € | ||
| 100mg | 458.00 € | ||
| 500mg | 998.00 € | ||
| 1ml*10 (DMSO) | 85.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Product Information
Name:
Apraclonidine hydrochloride
Synonyms:
- Iopidine, ALO 2145, Apraclonidina, P-aminoclonidine, 4-Aminoclonidine, Apraclonidine HCl, Apraclonidinum
- 1,4-Benzenediamine, 2,6-dichloro-N-(4,5-dihydro-1H-imidazol-2-yl)-, monohydrochloride
- 1,4-Benzenediamine, 2,6-dichloro-N<sup>1</sup>-(4,5-dihydro-1H-imidazol-2-yl)-, hydrochloride (1:1)
- 1,4-Benzenediamine, 2,6-dichloro-N<sup>1</sup>-(4,5-dihydro-1H-imidazol-2-yl)-, monohydrochloride
- 2,6-Dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine hydrochloride
- 2,6-dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine hydrochloride (1:1)
- 2-(4-Amino-2,6-dichloroanilino)-2-imidazoline hydrochloride
- Al 02145
- Alo 2145
- Aplonidine hydrochloride
- See more synonyms
- Iopidine
- P-aminoclonidine hydrochloride
- p-Aminoclonidine monohydrochloride
CAS:
Description:
Apraclonidine hydrochloride (ALO 2145) is an α2-adrenergic agonist and a weak α-1 adrenergic receptor agonist. Apraclonidine hydrochloride lowers intraocular pressure in human eyes and can be used in studies about glaucoma therapy.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
281.57
Formula:
C9H11Cl3N4
Purity:
98.01%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T21371 Apraclonidine hydrochloride
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
